These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 1672603

  • 1. Required beta blocker profile in the elderly.
    Opie LH.
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1273-80. PubMed ID: 1672603
    [Abstract] [Full Text] [Related]

  • 2. Beta-blockers and renal function.
    Wilkinson R.
    Drugs; 1982 Mar; 23(3):195-206. PubMed ID: 6122552
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of celiprolol, a new cardioselective beta 1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly.
    Lamon KD.
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1291-5. PubMed ID: 1672605
    [Abstract] [Full Text] [Related]

  • 4. Beta-blockers and the kidney.
    Epstein M, Oster JR.
    Miner Electrolyte Metab; 1982 Nov; 8(5):237-54. PubMed ID: 6132329
    [No Abstract] [Full Text] [Related]

  • 5. Angina, ischemia, and effort tolerance with vasodilating beta-blockers.
    Dargie HJ, Grant S, McLenachan J.
    Am Heart J; 1991 Mar; 121(3 Pt 2):1017-20. PubMed ID: 1671726
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Beta blockers and renal function: a reappraisal.
    Epstein M, Oster JR.
    J Clin Hypertens; 1985 Mar; 1(1):85-99. PubMed ID: 2873206
    [Abstract] [Full Text] [Related]

  • 8. Clinical and hemodynamic effects of celiprolol in essential hypertension.
    Parati G, Ravogli A, Bragato R, Omboni S, Mutti E, Mancia G.
    J Cardiovasc Pharmacol; 1989 Mar; 14 Suppl 7():S14-21. PubMed ID: 2481785
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.
    Heel RC, Brogden RN, Speight TM, Avery GS.
    Drugs; 1979 Jun; 17(6):425-60. PubMed ID: 38096
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Should beta-blockers be used to control hypertension in people with chronic kidney disease?
    Hart PD, Bakris GL.
    Semin Nephrol; 2007 Sep; 27(5):555-64. PubMed ID: 17868793
    [Abstract] [Full Text] [Related]

  • 16. Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties. The CELICARD Group.
    Witchitz S, Cohen-Solal A, Dartois N, Weisslinger N, Juste K, Darmon JY.
    Am J Cardiol; 2000 Jun 15; 85(12):1467-71. PubMed ID: 10856394
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alterations in renal hemodynamics during chronic and acute beta-blockade in humans.
    Beaufils M.
    Am J Hypertens; 1989 Nov 15; 2(11 Pt 2):233S-236S. PubMed ID: 2573369
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.